Literature DB >> 6775006

Biochemical properties of CO2-dependent streptococci.

L Pulliam, R K Porschen, W K Hadley.   

Abstract

A total of 153 clinical isolates and 10 reference strains were employed in an investigation of CO2-dependent streptococci. Their selection was based on a lactic acid homofermentative end product. This group of organisms grew best in 5 to 10% CO2, and several species, including Streptococcus mutans, S. intermedius, Streptococcus MG, S. anginosus, and S. constellatus, required increased CO2 for primary recovery. A basal medium of thioglycolate with 0.1% Tween 80 and phenol red was prepared and used with selected carbohydrates. This media provided luxuriant growth. Serological testing failed to give any definitive correlation with species identification. A shortened differentiation scheme, combined from previous studies, was proposed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775006      PMCID: PMC273513          DOI: 10.1128/jcm.12.1.27-31.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  [Pathogenic strains of Streptococcus viridans; streptocci found in dental abscesses and infiltrates in the region of the oral cavity].

Authors:  O GUTHOF
Journal:  Zentralbl Bakteriol Orig       Date:  1956-09

3.  Carbon dioxide requirement of group F and minute colony G hemolytic streptococci.

Authors:  P LIU
Journal:  J Bacteriol       Date:  1954-09       Impact factor: 3.490

4.  Streptococcus milleri (Guthof); an indigenous organism of the human oral cavity.

Authors:  B Mejàre; S Edwardsson
Journal:  Arch Oral Biol       Date:  1975-11       Impact factor: 2.633

5.  Infection with minute-colony-forming beta-haemolytic streptococci.

Authors:  P M Poole; G Wilson
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

6.  Presumptive identification of group A, B, and D streptococci.

Authors:  R R Facklam; J F Padula; L G Thacker; E C Wortham; B J Sconyers
Journal:  Appl Microbiol       Date:  1974-01

7.  A biochemical scheme for the separation of the five varieties of Streptococcus mutans.

Authors:  I L Shklair; H J Keene
Journal:  Arch Oral Biol       Date:  1974-11       Impact factor: 2.633

8.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

9.  Extracellular deoxyribonuclease production by anaerobic bacteria.

Authors:  R K Porschen; S Sonntag
Journal:  Appl Microbiol       Date:  1974-06

10.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

View more
  14 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Quantitative assay of glycocalyx produced by viridans group streptococci that cause endocarditis.

Authors:  L Dall; B Herndon
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

Review 3.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection.

Authors:  J A Jacobs; E E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

5.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

6.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Exopolysaccharide production by viridans streptococci in experimental endocarditis.

Authors:  J Mills; L Pulliam; L Dall; J Marzouk; W Wilson; J W Costerton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci.

Authors:  J Lawrence; D M Yajko; W K Hadley
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

9.  Nutritionally variant streptococci from corneal ulcers in horses.

Authors:  R Higgins; E L Biberstein; S S Jang
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

10.  Hydrolytic enzymes of "Streptococcus milleri".

Authors:  K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.